Peptides for Fat Loss & Weight Management
From breakthrough triple agonists (Retatrutide) and dual GIP/GLP-1 analogues (Tirzepatide) to selective lipolytic fragments (AOD-9604) and mitochondrial AMPK activators (MOTS-c), explore the clinical evidence for peptide-mediated adipose reduction.
🏆 Ranked Peptides for Peptides for Fat Loss & Weight Management
| Peptide | Efficacy Tier | Clinical Rationale | Dosage Summary |
|---|---|---|---|
| Retatrutide | Gold Standard | Demonstrated up to 24.2% mean body weight loss in Phase 2 clinical trials via triple receptor agonism. | 0.5mg - 2mg weekly initiating dose, escalating to 4-12mg maintenance. |
| Tirzepatide | Gold Standard | Dual GIP/GLP-1 agonist with proven 20-22.5% body weight reduction across SURMOUNT trials. | 2.5mg weekly for 4 weeks, titrating in 2.5mg steps up to 15mg. |
| Cagrilintide | High Efficacy | Dual amylin and calcitonin receptor agonist that delays gastric emptying and enhances GLP-1 satiety. | 0.3mg to 2.4mg weekly subcutaneous. |
| AOD-9604 | High Efficacy | Modified C-terminal fragment of hGH (177-191) that stimulates lipolysis without altering IGF-1 or blood glucose. | 300mcg - 500mcg daily fasted in the morning. |
📋 Clinical Protocol Recommendation
Combine a baseline incretin agonist (Tirzepatide or Retatrutide) with resistance training and high dietary protein (1.6-2.2g/kg) to maximize visceral fat loss while preserving lean skeletal muscle.
Frequently Asked Questions
❓ Which peptide produces the highest percentage of fat loss in clinical trials?
Retatrutide currently holds the record with up to 24.2% mean body weight reduction in 48-week Phase 2 trials, outperforming Tirzepatide (20.9%) and Semaglutide (14.9%).
❓ How do you prevent muscle loss when taking weight-loss peptides?
Consuming adequate protein (1.6–2.2g per kg of body weight daily) alongside progressive resistance training 3-4 times weekly is essential to prevent skeletal muscle catabolism during rapid weight loss.